Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Metal containing – e.g. – chromoproteins – ferritin,...
Reexamination Certificate
2006-10-24
2006-10-24
Kerr, Kathleen M (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Metal containing, e.g., chromoproteins, ferritin,...
C530S350000, C530S395000, C514S008100, C514S006900, C424S009100, C424S085100
Reexamination Certificate
active
07125963
ABSTRACT:
A method of preparing an ultra-cleansed lactoferrin preparation, termed treatment for contaminant reduction (TCR) is provided which includes the steps of treating commercial lactoferrin preparation with at least one each of surfactants, antioxidants and polyphenols to form purified lactoferrin (LF-TCR) and drying the LF-TCR. Additionally a therapeutic lactoferrin composition is provided which contains LF-TCR and optionally surfactants, antioxidants, polyphenols, tissue/membrane diffusion facilitating agents and anionic compounds. The therapeutic lactoferrin composition can additionally contain bioactive agents, dietary supplements, nutraceuticals/functional foods, prophylactic agents, therapeutic agents and probiotic lactic acid bacteria.
REFERENCES:
patent: 4436658 (1984-03-01), Peyrouset et al.
patent: 4518696 (1985-05-01), Gehrman et al.
patent: 4591499 (1986-05-01), Linn et al.
patent: 4668771 (1987-05-01), Kawakami et al.
patent: 4791193 (1988-12-01), Okonogi et al.
patent: 4997914 (1991-03-01), Kawakami et al.
patent: 5149647 (1992-09-01), Burling
patent: 5156875 (1992-10-01), Monte
patent: 5179197 (1993-01-01), Uchida et al.
patent: 5206156 (1993-04-01), Samain et al.
patent: 5214028 (1993-05-01), Tomita et al.
patent: 5240909 (1993-08-01), Nitsche
patent: 5296464 (1994-03-01), Tomita et al.
patent: 5389611 (1995-02-01), Tomita et al.
patent: 5516675 (1996-05-01), Uchida et al.
patent: 5543392 (1996-08-01), Tomita et al.
patent: 5571896 (1996-11-01), Conneely et al.
patent: 5596082 (1997-01-01), Kussendrager et al.
patent: 5606086 (1997-02-01), Dosako et al.
patent: 5639467 (1997-06-01), Dorian et al.
patent: 5656268 (1997-08-01), Sorodsky
patent: 5756680 (1998-05-01), Ahmed et al.
patent: 5834424 (1998-11-01), Valenti et al.
patent: 5849885 (1998-12-01), Nuyens et al.
patent: 5861491 (1999-01-01), Nuijens et al.
patent: 5869446 (1999-02-01), Valenti et al.
patent: 5895648 (1999-04-01), Vesely et al.
patent: 5919913 (1999-07-01), Nuyens et al.
patent: 5922375 (1999-07-01), Luchansky et al.
patent: 5955086 (1999-09-01), DeLuca et al.
patent: 6010698 (2000-01-01), Kussendrager et al.
patent: 6066469 (2000-05-01), Kruzel et al.
patent: 6080559 (2000-06-01), Conneely et al.
patent: 6093394 (2000-07-01), Chrisope
patent: 6140355 (2000-10-01), Egidio et al.
patent: 6172040 (2001-01-01), Naidu
patent: 6268487 (2001-07-01), Kutzko et al.
patent: 6306391 (2001-10-01), Modi et al.
patent: 6333311 (2001-12-01), Nuijens et al.
patent: 6372209 (2002-04-01), Chrisope
patent: 6399570 (2002-06-01), Mann
patent: 6436453 (2002-08-01), van Lengerich et al.
patent: 6475511 (2002-11-01), Gohlke et al.
patent: 2001/0001711 (2001-05-01), Olshenitsky et al.
patent: 2002/0004073 (2002-01-01), Gohlke et al.
patent: 2002/0048567 (2002-04-01), Olshenitsky et al.
patent: 2002/0081311 (2002-06-01), Shanahan et al.
patent: 2002/0090365 (2002-07-01), Chrisope
patent: 2002/0094328 (2002-07-01), De Simone
patent: 2002/0119237 (2002-08-01), Hevey
patent: 2003/0003059 (2003-01-01), Dana
patent: 2004/0043922 (2004-03-01), Naidu
patent: 0271364 (1992-09-01), None
patent: 0568200 (1993-03-01), None
patent: 0753308 (1997-01-01), None
patent: 0753309 (1997-01-01), None
patent: 2099065 (1997-12-01), None
patent: WO 91/13982 (1991-09-01), None
patent: WO 93/01823 (1993-02-01), None
patent: WO 98/55131 (1998-12-01), None
patent: WO 00/72690 (2000-12-01), None
patent: WO 00/72874 (2000-12-01), None
patent: WO 01/11077 (2001-02-01), None
Aeschbach R et al., Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol 32:31-6, 1994.
Alugupalli, K.R. et al. Lactoferrin Interaction withActinobacillus actinomycetermcomitans. Oral Micro. Immunol., 10:35-41, 1995.
Alugupalli, K.R. et al. Effect of Lactoferrin on Interaction ofPrevotella intermediawith Plasma and Subepithelial Matrix Proteins. Oral Microbiol Immunol, 9:174-179, 1994.
Appelmelk BJ et al., Lactoferrin is a lipid A binding protein. Infect Immun 62:2628-2632, 1994.
Axelsson L, Lactic acid bacteria—classification and physiology. In ‘Lactic acid bacteria—microbiology and functional aspects’, ed. S Salminen, pp. 1-72. New York: Marcel Dekker, 1998.
Bennett RM et al., Calcium-dependant polymerization of lactoferrin. Biochem Biophys Res Commun 101:88-95, 1981.
Benzie IF, Strain JJ, Ferric reducing antioxidant poser as a measure of antioxidant capacity: the FRAP assay. In: ‘Methods in Enzymology: Oxidants and Antioxidants’, et. L/ Packer, pp15-27, Orlando, FL, Academic Press, 1999.
Bhat VB, Madyastha KM, Scavenging of peroxynitrite by phycocyanin and phycocyanobilin fromSpirulina platensis—protection against oxidative damage to DNA. Biochem Biophys Res Comm 285:262-6, 2001.
Bors W et al., Flavonoids and phytophenols—chemistry and biology. In ‘Handbook of Antioxidants’, ed. Cadenas E, Packer L, pp. 409-466. New York: Marcel Dekker, 1996.
Burrin DG et al., Orally administered lactoferrin increases hepatic protein synthesis in formula-fed newborn pigs. Pediatr Res 40:72-6, 1996.
Caccavo D et al., Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic applications. J Endotoxin Res 8:403-17, 2002.
Chan MM et al., Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett 96:23-29, 1995.
Cheynier V, Rigaud J, HPLC separation and characterization of flavonols in the skins ofVitis vinferavar. Cinsault. Am J Enol Vitic 37:248-52, 1986.
Cho, Jin-Kook et al., Purification of Membrane-bound Lactoferrin from the Human Milk Fat Globule Membrane, Biosci. Biotechnol. Biochem., 64: 633-635, 2000.
Conway P, Selection criteria for probiotic microorganisms. Asia Pacific J Clin Nutr 5:10-14, 1996.
Cox TM, et al., Iron-binding proteins and influx of iron across the duodenal brush border. Evidence for specific lactotransferrin receptors in the human small intestine. Biochem Biophys Acta 588:120-8, 1979.
Crosa JH, Genetics and molecular biology of siderophore-mediated iron transport in bacteria. Microbiol. Rev. 53:517-30, 1989.
Davidson PM, Naidu AS Polyphenols, In ‘Natural Food Antimicrobial Systems’, ed. AS Naidu, pp. 265-294. Boca Raton: CRC Press, 2000.
Debbabi H et al., Bovine lactoferrin induces both mucosal and system immune responses in mice. J Dairy Res 65:283-93, 1998.
Elass-Rochard E et al., Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding toE. coli055B5 lipopolysaccharide. Biochem J 312:839-45, 1995.
Erdei, J. et al. Lactoferrin Binds to Porins OmpF and OmpC inEscherichia coli. Infect. Immunity, , 62:1236-1240, 1994.
Erridge C et al., Structure and function of lipopolysaccharides. Microbes Infect 4:837-51, 2002.
Fuda, E. et al. Recovery of Lactoferrin and Lactoperoxidase from Sweet Whey Using Colloidal Gas Aphrons (CGAs) Generated from an Anionic Surfactant, AOT. Biotechnol. Progr., 20:514-525, 2004.
Fuller, R. et al. Modification of the Intestinal Microflora Using Probiotics and Prebiotics. Scand . J. Gastroenterol. 32 Suppl:28-31, 1997.
Gadó, I. et al. Correlation Between Human Lactoferrin Binding and Colicin Susceptibility inEscherichia coli. Antimicrobial Agents Chemo., 35: 2538-2543, 1991.
Gemma C et al., Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines. J Neurosci 22:6114-20, 2002.
Gibson, G.R. et al. Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics. J. Nutr. 125:1401-1412, 1995.
Gibson G.R. et al. Probiotics and Intestinal Infections. In, Probiotics 2: Applications and Practical Aspects, R. Fuller, ed. Chapman & Hall, pp10-39, 1997.
Griffiths, E. et al. In Vitro Growth Responses of Bifidobacteria and Enteropathogens to Bovine and Human Lactoferrin. Digest. Dis. Sci., 48:1324-1332, 2003.
Harmon RJ et al., Changes in lactoferrin, immunoglobulin G, bovine serum albumin, and α-inflammation-induce
Kam Chih-Min
Kerr Kathleen M
LandOfFree
Treatments for contaminant reduction in lactoferrin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatments for contaminant reduction in lactoferrin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatments for contaminant reduction in lactoferrin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3674124